Statens Serum Institut
28 clinical trials · Sponsor
◉ Watch Statens Serum Institut
| Record | Firm | Date |
|---|---|---|
| First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b (NCT06050356) | Statens Serum Institut | 2024-03-14 |
| Safety and Immunogenicity of a Chlamydia Vaccine CTH522 (NCT03926728) | Statens Serum Institut | 2020-02-17 |
| Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months (NCT03671616) | Statens Serum Institut | 2018-05-15 |
Track Statens Serum Institut automatically
Every clearance here is in the API, with alerts when new ones post.